CAR-T Cell Therapy for Acute Myeloid Leukemia: Where Do We Stand Now?
<b>Background</b>: Patients with refractory and relapsed acute myeloid leukemia (R/R AML) face a dismal prognosis. CAR-T therapy has emerged as a potential treatment option. This study assesses the available clinical evidence on CAR-T in R/R AML, focusing on safety and efficacy outcomes. <b>Methods<...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
MDPI AG
2025-05-01
|
| Colección: | Current Oncology |
| Materias: | |
| Acceso en línea: | https://www.mdpi.com/1718-7729/32/6/322 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|